Abstract
Aim. The transcatheter aortic valve implantation (TAVI) which developed in the recent years has become an alternative for surgery. However, in spite of new developments the process based vascular and neurological complications still remain to be a problem with elderly patients who also tend to have many co-morbid conditions. With this study we aimed to evaluate the TAVI efficacy and reliability on patients with scarcely relative contraindication and with intracardiac thrombus who are mostly left out of the study. Methods and Results. There has been a successful TAVI process conducted in our clinic for antiplatelet and anticoagulation for 6 cases in which thrombus was seen in left atrial appendix (LAA) via transesophageal echocardiography (TEE) and which are not suitable for surgical valve replacement due to atrial fibrillation (AF) and severe AS comorbid reasons. Edwards SAPIEN XT valve was implanted to all patients transfemorally with general anaesthesia. The process was facilitated successfully and no major/minor stroke was observed in post-process early period, and 9 month controls, in average. Conclusion. Other than AS, also AF, whose frequency increases with age, is an important risk factor for neurological complications. In patients who has AF and AS the source of the cardioembolic focus is mainly LAA. The post-TAVI antiplatelet and anticoagulation treatment is not clear for these patients. We tried to show that TAVI process is reliable in terms of the risk of stroke, in careful processing and suitable anticoagulation treatment for the patients with AF, AS and LAA in this first case study in literature, as far as we know.
Highlights
The frequency of aortic stenosis (AS) gradually increases along with the increase in the life span
As no bleeding was observed in none of the patients, one patient was treated with a unit of erythrocyte suspension and the other was treated with two units, after the process
In our publication which is the first study in the literature, we presented the successfully applied transcatheter aortic valve implantation (TAVI) process without developing any stroke on the patients with thrombus in left atrial appendix (LAA) and atrial fibrillation (AF)
Summary
The frequency of aortic stenosis (AS) gradually increases along with the increase in the life span. According to the only randomized clinical study on this issue, PARTNER study, it has been shown that TAVI is superior to treatment in inoperable patients and could be a significant alternative in SAVR in patients carrying high risk [3, 4]. As well as it is a less invasive process when compared to surgery, major vascular complications and stroke is seen more often in TAVI process when compared to a surgical group.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
